Franklin Biolabs, headquartered in Philadelphia, has officially launched its operations, marking a significant entry into the genetic medicines sector. Founded by Dr. James Wilson, a renowned figure in gene therapy, the organisation is designed to provide comprehensive solutions from discovery
Recipharm, a global pharmaceutical contract development and manufacturing organisation (CDMO), has announced an expansion of its pharmaceutical development capabilities. This initiative aims to meet the growing demands of both early- and late-stage product development, which includes clinical study supply at
BioDuro-Sundia, a global CRDMO (Contract Research, Development, and Manufacturing Organization), has announced the launch of its new Compound Management Center in the Shanghai Free-Trade Zone, China. The facility aims to enhance the company’s drug discovery capabilities by offering systematic storage
“Building relationships and transparent communication are key to successful outsourcing in cell therapy manufacturing,” says Jessica Brantley, Senior Manager of External Manufacturing at Sonoma Biotherapeutics. Jessica Brantley, brings a wealth of experience from her roles at Novartis and a decade
ReiThera, a CDMO company dedicated to technology and process development and GMP manufacturing has initiated a Phase 2 clinical trial in Uganda for a vaccine targeting the Sudan ebolavirus, marking a significant step in addressing life-threatening infectious diseases. The trial
SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announced a multi-year agreement with biotechnology firm AaviGen GmbH. The agreement appoints SK pharmteco as the preferred manufacturing partner for AaviGen’s lead gene therapy product AVG-101, aimed at treating
LenioBio, a company specialising in cell-free protein expression technology, has entered a collaboration with ReciBioPharm, a contract development and manufacturing organisation (CDMO), to scale protein manufacturing and accelerate vaccine production. This partnership is part of an expansion of LenioBio’s CEPI-funded
Forge Biologics has introduced its new FUEL (Foundation for Unleashing Excellence in Life-Changing Therapies) manufacturing platform, aimed at providing AAV gene therapy developers with a faster and more efficient process for advancing their therapeutic programs. The platform’s launch includes technical
Agarose Bead Technologies (ABT) has completed a significant expansion of its facility in Burgos, Spain, adding 1000 sqm to boost its annual production capacity of agarose resins to 100,000 liters. This move positions the company among the largest agarose resin
Sharp, a provider of pharmaceutical contract packaging and clinical trial supply services, has announced its membership in the United Nations Global Compact, a voluntary corporate sustainability initiative. The company joins over 20,000 companies worldwide that support responsible business actions in
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
